This expanded patient cohort experience of first-line ICI treated metastatic NSCLC patients further demonstrates that plasma cfRNA PD-L1 expression by RT-PCR is associated with favorable ICI treatment outcomes. Here, CD274 is linked to non-small cell lung carcinoma.